Clinical trials are studies with volunteers that help researchers learn how to slow, manage, and treat different diseases. There are four phases of clinical trials that each help scientists answer different questions. Phase 1 clinical trials are the first step in testing a new treatment in people. They focus on evaluating the safety, side effects, best dose, and timing of a new treatment, according to the National Cancer Institute (NCI). Phase 1 clinical trials usually include a small number of patients who have not been helped by other treatments. In the past, participants in phase 1 trials for cancer treatment generally had low tumor response rates. And, because phase 1 trials are focused on assessing safety of treatments, doctors have hesitated to refer patients to these ...
COVID-19 is not over. For the past three years, the virus has disrupted life and health. Data continue to show that the pandemic worsened historical health and social inequities, especially for Latinos. How can we address this? Let’s use #SaludTues on Feb. 7, 2023, to explore health inequities facing the Latino population over the past three years (and long before that), and share solutions and strategies to promote health equity in the face of COVID-19! WHERE: Twitter
WHAT: #SaludTues Tweetchat “3 Years Later: How COVID-19 Is Impacting Latinos”
WHEN: 1-2 p.m. ET (12-1 p.m. CT), Tuesday, Feb. 7, 2023
HOST: Salud America! at UT Health San Antonio (@SaludAmerica)
CO-HOSTS: Latinx Voces LLC (@latinxvocesllc); LatinaStrong Foundation (@LatinaStrongDr); Public ...
If you’re age 75 or older, you should know about PREVENTABLE. PREVENTABLE – the Pragmatic Evaluation of events And Benefits of Lipid-lowering – is a clinical trial to help researchers understand if taking a statin, a drug commonly used to lower cholesterol in younger adults, is helpful for older adults, specifically when it comes to maintaining health by preventing dementia, disability, and heart disease. “We really don’t know how these drugs work in older adults,” according to the research team at UT Health San Antonio, including Dr. Sara Espinoza, principal investigator for the local study site. “Most, if not all, of the studies of statins have been done in much younger people, in their 50s and 60s, but studies in adults over 75 are rare.” The national study is ...
Have you ever had a conversation with a doctor that left you feeling confused? These situations can be frustrating, especially when it hurts your health. Unfortunately, poor doctor-patient communication is common, even though doctors acknowledge they should avoid medical jargon when talking with patients. In a new study in JAMA Network Open, researchers surveyed 215 adults and found that when medical jargon was used by physicians, participants frequently misunderstood and often interpreted the exact opposite of what the physician intended. This confusion can lead to adverse health outcomes, according to the study. "You could be the smartest doctor in the world, yet you're useless if your patients don't understand what you are saying," Dr. Michael Pitt, study author and ...
We use a lot of shared devices and equipment in healthcare. But these devices and equipment are all surfaces that can have germs on them. Because healthcare workers use and share devices and equipment many times a day and for many different tasks, it’s important to understand the role that these devices can play in the spread of germs.
Medical Devices
Medical devices are used on a patient’s body, such as a stethoscope or blood pressure cuff. They’re also used in a patient’s body, such as an IV needle, an endoscope, or an artificial hip. When devices are used on or in a patient’s body to provide care, any germs on those devices can spread to places in or on the patient’s body. That’s how devices can be the germ’s entryway into the body. Devices that are ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Conclusion
To eliminate cancer disparities in Latinx populations, Advancing the Science of Cancer in Latinos brought together researchers, scientists, physicians, healthcare professionals, patient advocates, and students from across the US and Latin America. These presenters shared research advancements, identified gaps, developed actionable goals, updated clinical best practices, described effective community interventions, and detailed professional training programs aimed at addressing inequity. In the process, most of the speakers made ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Using Science to Address Latino Health Disparities Research
Eliseo J. Pérez-Stable, M.D., is Director of the National Institute on Minority Health and Health Disparities (NIMHD) at the National Institutes of Health (NIH). Health disparities and social determinants of health Dr. Pérez-Stable began his presentation by discussing the ways in which science can reduce inequities in healthcare. First, standardized surveys, tools, and measurements are needed so that data can be combined, facilitating discovery through large data sets. ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Transformative Strategies for Integration of Health Equity Principles in Science and Access in the US
Dr. Edith A. Perez is the Serene M. and Frances C. Durling Professor of Medicine at the Mayo Clinic College of Medicine and the Chief Medical Officer at Bolt Biotherapeutics. Her presentation outlined strategies for health equity as exemplified by the National Academies of Sciences, Engineering, and Medicine (NASEM) Committee for Inclusion in Research, and the Health Equity Committee at Stand Up To Cancer (SU2C). The NASEM initiative, ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Leading Pathways: The Hispanic/Latino Survivorship Study
Dr. Frank Penedo is Associate Director of Cancer Survivorship & Behavioral Translational Sciences at the Sylvester Comprehensive Cancer Center at the University of Miami. The Leading Pathways study Dr. Penedo began by presenting a summary of Leading Pathways, a Hispanic/Latino survivorship study, a collaboration between the Mays Cancer Center at UT Health San Antonio and the Sylvester Comprehensive Cancer Center at the University of Miami. The study has five key aims, the ...
